Skip to main content
OpenTrials

Clinical trial condition

Heredodegenerative Disorders, Nervous System

Explore clinical trials studying Heredodegenerative Disorders, Nervous System. Study availability and eligibility vary by location and protocol.

1,879 public trials 409 recruiting studies
Refine in advanced search Browse all conditions

Heredodegenerative Disorders, Nervous System trial results

Completed

Randomized, Controlled Study Evaluating CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease

NCT00876863

Conditions
Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +23 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • University of California, San Diego San Diego, California, United States
  • Georgetown University Washington D.C., District of Columbia, United States
View Trial Details
Completed

A Phase I/II Study of BGT226 in Adult Patients With Advanced Solid Malignancies Including Patients With Advanced Breast Cancer

NCT00600275

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +21 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Faber Cancer Institute Boston, Massachusetts, United States
  • Nevada Cancer Center Las Vegas, Nevada, United States
  • Cancer Therapy and Research Center (CTRC) San Antonio, Texas, United States
View Trial Details
Completed

CANNAbinoids in the Treatment of TICS (CANNA-TICS)

NCT03087201

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +10 more
Locations
  • Uniklinik RWTH Aachen, Psychiatry and Psychotherapy Aachen, Germany
  • University Hospital Cologne, Psychiatry and Psychotherapy Cologne, Germany
  • University of Freiburg, Psychiatry and Psychotherapy Freiburg im Breisgau, Germany
  • Hannover Medical School, Clinic of Psychiatry, Socialpsychiatry and Psychotherapy Hanover, Germany
View Trial Details
Completed

Clinical Study to Assess the Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of AFQ056 in Children With Fragile X Syndrome (FXS)

NCT01482143

Conditions
Chromosome Disorders, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Novartis Investigative Site Sacramento, California, United States
  • Novartis Investigative Site Chicago, Illinois, United States
  • Novartis Investigative Site Nashville, Tennessee, United States
  • Novartis Investigative Site Sant Cugat del Vallès, Catalonia, Spain
View Trial Details
Completed

The Assessment of Copper Parameters in Wilson Disease Participants on Standard of Care Treatment

NCT02763215

Conditions
Basal Ganglia Diseases, Brain Diseases, Brain Diseases, Metabolic, +16 more
Locations
  • Clinical Trial Site New Haven, Connecticut, United States
  • Clinical Trial Site Chicago, Illinois, United States
  • Clinical Trial Site Ann Arbor, Michigan, United States
  • Clinical Trial Site Nashville, Tennessee, United States
View Trial Details

Related conditions